Literature DB >> 8852698

Selenium-mediated inhibition of transcription factor NF-kappa B and HIV-1 LTR promoter activity.

V Makropoulos1, T Brüning, K Schulze-Osthoff.   

Abstract

The eukaryotic transcription factor NF-kappa B is involved in the inducible expression of various inflammatory genes as well as in HIV-1 replication. Activation of NF-kappa B is induced by prooxidants and several stimuli eliciting oxidative stress, such as cytokines, lipopolysaccharide, UV irradiation and other mediators. Various antioxidants inhibit NF-kappa B activation in response to these stimuli. In this study, we have investigated the effects of selenium, an integral component of glutathione peroxidase (GPX), on NF-kappa B activation. In selenium-deprived Jurkat and ESb-L T lymphocytes, supplementation of selenium led to a substantial increase of GPX activity. Analysis of DNA binding revealed that NF-kappa B activation in response to TNF was significantly inhibited under these conditions. Likewise, reporter gene assays using luciferase constructs driven by the HIV-1 long terminal repeat showed a dose-dependent inhibition of NF-kappa B controlled gene expression by selenium. The effects of selenium were specific for NF-kappa B, since the activity of the transcription factor AP-1 was not suppressed. These data suggest that selenium supplementation may be used to modulate the expression of NF-kappa B target genes and HIV-1.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8852698     DOI: 10.1007/s002040050274

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  13 in total

1.  Selenium and the "free" electron. Selenium--a trace to be followed in septic or inflammatory ICU patients?

Authors:  X Forceville
Journal:  Intensive Care Med       Date:  2001-01       Impact factor: 17.440

2.  [Significance of selenium in regulation of inflammatory response by transcription factors in polytrauma patients. A clinical study].

Authors:  G von Gagern; T Zimmermann; S Albrecht; L Bachmann; H Zwipp; H D Saeger
Journal:  Med Klin (Munich)       Date:  1999-10-15

3.  Inhibition of NF-kappaB DNA binding and nitric oxide induction in human T cells and lung adenocarcinoma cells by selenite treatment.

Authors:  I Y Kim; T C Stadtman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

Review 4.  Chemopreventive mechanisms of selenium.

Authors:  G F Combs
Journal:  Med Klin (Munich)       Date:  1999-10-15

Review 5.  Role of selenium in HIV infection.

Authors:  Cosby A Stone; Kosuke Kawai; Roland Kupka; Wafaie W Fawzi
Journal:  Nutr Rev       Date:  2010-11       Impact factor: 7.110

6.  Interleukin-1-induced nuclear factor kappa B activation is inhibited by overexpression of phospholipid hydroperoxide glutathione peroxidase in a human endothelial cell line.

Authors:  R Brigelius-Flohé; B Friedrichs; S Maurer; M Schultz; R Streicher
Journal:  Biochem J       Date:  1997-11-15       Impact factor: 3.857

7.  Human thioredoxin reductase from HeLa cells: selective alkylation of selenocysteine in the protein inhibits enzyme activity and reduction with NADPH influences affinity to heparin.

Authors:  S N Gorlatov; T C Stadtman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

8.  xCT/SLC7A11 antiporter function inhibits HIV-1 infection.

Authors:  Jesse Rabinowitz; Hamayun J Sharifi; Hunter Martin; Anthony Marchese; Michael Robek; Binshan Shi; Alexander A Mongin; Carlos M C de Noronha
Journal:  Virology       Date:  2021-01-20       Impact factor: 3.616

9.  How to use the world's scarce selenium resources efficiently to increase the selenium concentration in food.

Authors:  Anna Haug; Robin D Graham; Olav A Christophersen; Graham H Lyons
Journal:  Microb Ecol Health Dis       Date:  2007-12

10.  Effects of high doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind, phase II study.

Authors:  Xavier Forceville; Bruno Laviolle; Djillali Annane; Dominique Vitoux; Gérard Bleichner; Jean-Michel Korach; Emmanuel Cantais; Hugues Georges; Jean-Louis Soubirou; Alain Combes; Eric Bellissant
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.